Your browser doesn't support javascript.
loading
Functional Competence of NK Cells via the KIR/MHC Class I Interaction Correlates with DNAM-1 Expression.
Shang, Qian-Nan; Yu, Xing-Xing; Xu, Zheng-Li; Cao, Xun-Hong; Liu, Xue-Fei; Zhao, Xiao-Su; Chang, Ying-Jun; Wang, Yu; Zhang, Xiao-Hui; Xu, Lan-Ping; Liu, Kai-Yan; Huang, Xiao-Jun; Zhao, Xiang-Yu.
Affiliation
  • Shang QN; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Yu XX; Peking-Tsinghua Center for Life Sciences, Beijing, China; and.
  • Xu ZL; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Cao XH; Peking-Tsinghua Center for Life Sciences, Beijing, China; and.
  • Liu XF; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Wang Y; Peking-Tsinghua Center for Life Sciences, Beijing, China; and.
  • Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Zhao XY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.
J Immunol ; 208(2): 492-500, 2022 01 15.
Article in En | MEDLINE | ID: mdl-34937746
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Histocompatibility Antigens Class I / Antigens, Differentiation, T-Lymphocyte / Receptors, KIR Type of study: Observational_studies Limits: Humans Language: En Journal: J Immunol Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Histocompatibility Antigens Class I / Antigens, Differentiation, T-Lymphocyte / Receptors, KIR Type of study: Observational_studies Limits: Humans Language: En Journal: J Immunol Year: 2022 Type: Article Affiliation country: China